# IMS® DIAREG Diabetes Registry - Prospective Diabetes Registry of Patients With Type 2 Diabetes Mellitus

> **NCT01906294** · — · TERMINATED · sponsor: **IMS HEALTH GmbH & Co. OHG** · enrollment: 2104 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** antidiabetic treatment (ATC A10B)

## Key facts

- **NCT ID:** NCT01906294
- **Lead sponsor:** IMS HEALTH GmbH & Co. OHG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2013-08
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 2104 (ACTUAL)
- **Why stopped:** Representativeness and results about treatment and health condition available
- **Last updated:** 2016-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01906294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01906294, "IMS® DIAREG Diabetes Registry - Prospective Diabetes Registry of Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT01906294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*